Skip to content

Instantly share code, notes, and snippets.

@terabyte
Created June 12, 2026 23:50
Show Gist options
  • Select an option

  • Save terabyte/4f162ee6daa2ee43b797adce83171032 to your computer and use it in GitHub Desktop.

Select an option

Save terabyte/4f162ee6daa2ee43b797adce83171032 to your computer and use it in GitHub Desktop.
Fact-check: 'Aurivita Capsaicin Power' Type 2 diabetes supplement marketing copy — claim-by-claim evaluation with primary sources

Source: "Aurivita Capsaicin Power" direct-response marketing copy

Reproduced verbatim for fact-checking purposes. This is advertising copy for a dietary supplement; it is not medical advice and several of its claims are distorted or unsupported (see the companion analysis). The text cuts off mid-sentence at the end exactly as received.


When a diabetic man dies, the coroner doesn't write "diabetes" on the death certificate. He writes heart attack. Or stroke. Or kidney failure. Or sepsis from an infected foot. Diabetes is almost never the official cause of death — even though it's almost always the actual one.

There is a reason for that, and it has nothing to do with paperwork.

It has to do with where diabetes does its real damage.

And once you understand where, you understand why metformin, statins, and Ozempic have never once "fixed" anyone — and why a Nobel Prize awarded in October 2021 may matter more to you, personally, than any drug your doctor has ever prescribed.

I want to tell you what Type 2 diabetes actually is. Not the textbook definition. The real one.

Type 2 diabetes is a disease of the blood vessels disguised as a disease of blood sugar.

The high glucose is the symptom you can measure. It's the number on the lab report. It's the thing your A1C tracks. It's what every drug in the standard protocol is built to lower.

But the actual damage — the damage that takes feet, takes sight, takes kidneys, takes erections, and eventually takes lives — is happening one layer underneath. In the lining of the smallest arteries in your body. In a single sheet of cells called the endothelium that wraps the inside of every vessel from your aorta down to the capillaries feeding the nerves in your toes.

The endothelium is, by surface area, the largest organ in your body. About the size of a tennis court if you laid it flat. And its job is to produce a tiny molecule called nitric oxide — the molecule that tells your blood vessels when to relax and let blood flow through. Nitric oxide is what keeps your blood pressure stable. It is what delivers oxygen and nutrients to your nerves, your kidneys, your eyes, and yes — your erectile tissue.

When the endothelium is healthy, nitric oxide flows. Your feet stay warm. Your kidneys filter. Your eyes see clearly. You can be a man with your wife. Your heart pumps without strain.

But here's what 5, 10, 15 years of high blood sugar does to that endothelium. It poisons it.

Glucose molecules — the same ones spiking and crashing in your bloodstream every day — physically damage the endothelial cells lining your microscopic vessels. They cause something called glycation, which is sugar-coating of proteins. And a state called oxidative stress, which is rust, basically.

The endothelium stops producing nitric oxide. The vessels can't relax. Blood stops reaching the nerves in your feet — that is why they burn at 3 a.m. Blood stops reaching the filters in your kidneys — that is why your creatinine is creeping up. Blood stops reaching the chambers of erectile tissue — that is why you can't perform like you used to. Blood stops reaching the rods and cones in your eyes — that is why you have floaters. Blood stops reaching the fine arteries feeding your heart muscle — that is why diabetic men have heart attacks at multiples of the rate non-diabetic men do.

It's all the same disease.

ED. Neuropathy. Retinopathy. Kidney decline. Heart attack risk. They are not five separate complications. They are five faces of one problem — damaged blood vessels and a starved endothelium.

The Mayo Clinic admits this on their own patient pages. The Cleveland Clinic admits it. The words "blood vessel damage" appear in the first paragraph of both. Your doctor knows this. Your doctor has known this since medical school.

Now here is the part that should make you angry.

There is not a single drug in the standard diabetic protocol that targets the endothelium itself.

Metformin doesn't. Statins don't. Glipizide doesn't. Ozempic doesn't. ACE inhibitors and beta blockers lower the pressure in damaged vessels, but they don't repair the lining. The standard protocol manages your numbers while the actual machinery — the tennis-court-sized organ that decides whether you keep your foot, your sight, your kidneys, and your sex life — gets quietly destroyed.

And then, when a complication finally surfaces, they prescribe another drug to manage that number.

That is not treatment. That is a treadmill.

I have been calling it the walking pharmacy treadmill — and you have been on it for years.

You started on metformin. Then they added a statin. Then a blood pressure med, maybe two because the first one made you cough. Then maybe glipizide because the metformin "wasn't enough anymore." Then a beta blocker because your cardiologist got nervous. Then maybe an Ozempic shot, until you saw the gastroparesis lawsuits on the news and quietly stopped.

Maybe right now, this morning, you are five pills deep before your first cup of coffee. And you have started to rattle when you walk.

And the conversation at every appointment is the same. Your A1C is creeping again. Your blood pressure is creeping again. Let's add another one and see you in three months.

Add. Add. Add. Never take away. Never fix. Never finish. Just one more pill. And one more. And one more. Forever.

Your doctor is not the one who is going to step you off this treadmill. I want to say that carefully, because I respect doctors. Most of them are good people working inside a broken machine. But I have to be honest with you about how the machine works.

Your doctor has 7 minutes with you. Maybe 12 if you're lucky. Your doctor was trained — for four years of medical school and three to five years of residency — in a system that teaches diabetes as a progressive disease that can only be managed. Not reversed. Managed.

In 2018, a board-certified physician named Dr. Sarah Hallberg — medical director of the Virta Health diabetes reversal program — gave a TED talk titled "Reversing Type 2 Diabetes Starts With Ignoring the Guidelines." It has been viewed over 12 million times. Her argument was simple. The standard guidelines have been making her diabetic patients sicker. The protocol of "balanced plate plus slowly escalating medications" was a treadmill. Real reversal was possible — but only by ignoring the dogma she'd been taught.

Dr. Hallberg died in March 2022. In her last interviews, she warned that the system was not going to change quickly. That doctors trained in the old paradigm would keep prescribing the old protocol. That patients themselves would have to take the lead.

I'm telling you this because she's not coming back, and there aren't enough doctors like her to go around. There are maybe a few hundred "doctors who left the system" in the entire English-speaking world. There are 37 million diabetic Americans. You are not going to get a Hallberg. You are going to get the family doc who has 11 minutes for you and another patient in the waiting room.

So you are going to have to take the lead. Not by firing your doctor. Not by stopping your medications. Not by doing anything reckless. By learning what the system was never set up to teach you — how to support the one organ that determines whether the next 20 years of your life look like your father's last 5 years, or whether you walk your daughter down the aisle and dance at her wedding instead.

The endothelium.

In October of 2021, a researcher named Dr. David Julius, at the University of California, San Francisco, was awarded the Nobel Prize in Physiology or Medicine. He shared it with Dr. Ardem Patapoutian. Their discovery was a tiny molecular doorway on the surface of human cells called TRPV1 — the transient receptor potential vanilloid 1 receptor.

TRPV1 is what makes spicy food feel hot. It is the receptor that responds to capsaicin — the active compound in cayenne pepper. But that wasn't why it won a Nobel Prize. It won a Nobel Prize because of what TRPV1 does inside the lining of your blood vessels.

In 2010, a team of researchers led by Dr. Dachun Yang published a landmark paper in the journal Cell Metabolism — one of the most prestigious scientific journals in the world. The title: "Activation of TRPV1 by Dietary Capsaicin Improves Endothelium-Dependent Vasorelaxation and Prevents Hypertension."

In plain English: chronic, low-dose dietary capsaicin activates the TRPV1 receptor, which triggers a cascade ending in increased nitric oxide production by the endothelial cells lining your blood vessels.

It was the same molecule — nitric oxide — that had already won the 1998 Nobel Prize in Medicine for Drs. Louis Ignarro, Robert Furchgott, and Ferid Murad.

Two separate Nobel Prizes — 1998 and 2021 — pointing at the same pathway. A specific receptor on your endothelial cells, activated by a specific dietary compound, triggering production of a specific signaling molecule, which restores function to the largest, most-damaged organ in a diabetic body.

In 2023, Dr. Arpad Szallasi published a comprehensive review summarizing the evidence — including a Chinese epidemiological study of over 9,000 volunteers linking dietary capsaicin intake to lower rates of high blood pressure.

I want to be careful and honest with you here, the way I wish more people in this industry were.

This research is not a cure for diabetes. It is not a replacement for working with your doctor. The strongest evidence is in animal studies and mechanism studies. The human clinical-trial evidence on capsaicin specifically is still maturing. Anybody who tells you a softgel "cures" or "reverses" diabetes is lying to you, and you should close their page immediately.

But what this research does support is something far more important than another miracle claim. That there is a real, scientifically validated, Nobel-recognized molecular pathway for supporting the function of the blood vessels that diabetes spends years attacking. A pathway your doctor was almost certainly never trained on, because medical schools update their curricula on a 20-to-30-year lag. A pathway that involves food, not patents — which is one reason no pharmaceutical company has spent $400 million bringing it to market as a drug.

This is where Aurivita Capsaicin Power comes in.

I'm not going to insult your intelligence with a "secret formula" pitch. You've seen too many of those. GlucoTrust. Sugar Defender. Halki. Gluco6. The Greek-island ritual. The 60-second salad-dressing. The parasite-cleanse-for-diabetes scam. You've been burned. So have your friends. So have your brothers-in-law. I'm going to do the opposite. I'm going to tell you exactly what's in the bag, exactly how much, and exactly why.

Aurivita Capsaicin Power is built around 3 milligrams of standardized capsaicin per serving — extracted from cayenne pepper and delivered in a softgel format specifically designed not to burn your stomach. The number one reason men quit raw cayenne capsules is the GI burn. We solved that. Three milligrams is a thoughtful, low daily dose — enough to engage the TRPV1 pathway without the heartburn or the acute spike that high oral doses can sometimes cause.

But capsaicin alone is only one piece of the picture. The endothelium has multiple input pathways for nitric oxide production. So we built a stack of nine companion ingredients, each one chosen because there is published human research on its role in either nitric oxide signaling, healthy blood vessel function, or healthy blood sugar already in the normal range.

Beetroot — rich in dietary nitrate, which the body converts through a separate pathway from citrulline into nitric oxide. A 2017 meta-analysis in Advances in Nutrition found that beetroot supplementation lowered systolic blood pressure by an average of 3.55 mmHg.

Berberine — sometimes called "nature's metformin." A 2008 trial in the journal Metabolism found that 0.5 grams of berberine three times a day reduced HbA1c by approximately 2 percentage points in newly-diagnosed Type 2 diabetic patients, comparable to metformin itself.

Cinnamon — a 2024 meta-analysis of 28 randomized trials covering more than 3,000 Type 2 diabetic patients found cinnamon supplementation reduced fasting blood glucose by 15.3 mg/dL and HbA1c by 0.56 percent.

Turmeric, paired with BioPerine for absorption — a 2024 meta-analysis of 18 randomized trials in Type 2 diabetic patients found curcumin reduced fasting blood glucose by 11.5 mg/dL and HbA1c by 0.54 percent, while reducing markers of inflammation. BioPerine increases curcumin absorption by approximately 20 times.

Hawthorn — a European folk-medicine cardiac tonic going back to the medieval period, validated by modern clinical trials. Used in the formula to support the larger cardiovascular system that the endothelium feeds into.

Korean Red Ginseng — multiple Toronto-led randomized trials have shown modest improvements in fasting blood glucose and insulin sensitivity in Type 2 diabetic patients.

Vitamin D3 paired with K2 — D3 deficiency is rampant in diabetic men, and meta-analyses have shown modest improvements in insulin sensitivity in deficient patients on supplementation. K2 is the partner nutrient that helps the body direct calcium into bones and away from arterial walls — a particular concern in diabetic patients prone to vascular calcification.

And Vitamin E as the antioxidant capstone — protecting the polyunsaturated fats inside the softgel itself and supporting general antioxidant capacity in the bloodstream.

That is the formula. Nine ingredients. Each one published. Each one disclosed in milligrams on the label — no proprietary blends hiding behind a fairy-tale name. Three softgels a day. Six bottles a year. That is the entire program.

I want to draw a hard line, because if I don't, I'm no better than the GlucoTrust crowd.

Aurivita Capsaicin Power is not a cure for diabetes. There is no such thing as a softgel cure for diabetes. Anyone who tells you otherwise is selling you a fairy tale. It is not a replacement for the medications your doctor has prescribed. Do not stop your metformin, your statin, your blood pressure medication, or anything else without your doctor's involvement. When you start to see your numbers move — and many men do — bring those numbers to your doctor and ask them about tapering. That is the right path.

It is not a license to keep eating the way that got you here. The single most powerful intervention in Type 2 diabetes remains lifestyle — reduced carbohydrate intake, weight loss, sleep, walking, strength training. Aurivita is built to support those levers, not replace them.

It is not instant. Your endothelium has been under attack for somewhere between 5 and 20 years. It is not going to fully reset in 5 days. The ingredients that act fastest — L-citrulline, beetroot, capsaicin — begin engaging the nitric oxide pathway within days. The deeper work of supporting healthy vessel function and healthy blood sugar levels happens over weeks and months. That is why our money-back guarantee is 120 days, not 30. We want you to have enough time to actually see what happens.

That is the line. Now let me tell you what the men who are using Aurivita have started to notice. By law, I have to remind you that results are not typical, your individual results may vary, and these statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

With that understood — the first thing most men notice is warmth. Cold hands warming up. Cold feet, in particular, warming up. This is one of the most common pieces of feedback in the first two to three weeks. It is consistent with what the published literature would predict from improved peripheral circulation.

The second thing most men notice is sleep. The 3 a.m. burning that has been waking them up — a lot of men report it gets quieter. Not gone, in a lot of cases. Quieter. Enough to sleep through.

The third thing is energy. Specifically, the afternoon crash starts to fade. The 2 p.m. wall doesn't show up the same way. Men describe walking past the coffee machine at 3:30 and not needing it.

The fourth thing is the bedroom. I'm not going to dress this up. Many men report that things their wife had stopped expecting started happening again. They start telling their friends. They start telling us.

The fifth thing — and this is the one that takes 2 to 4 months — is the bloodwork. A lot of men come back from their next quarterly appointment with an A1C that is half a point lower, or a full point lower, than the one before. Their doctor looks at the chart and asks them what they've changed. They tell their doctor. Some doctors are intrigued. Some are skeptical. Almost all of them say, keep doing whatever you're doing.

The deepest piece of feedback we ever got — and I think about this one a lot — was from a man in Tennessee who wrote to us six months in to say: "I went to my dad's grave on the anniversary. He died at 63. I'm 61. For the first time in ten years, I don't think I'm going next." I read that letter to the team out loud. That is why we built this.

I know you're skeptical. You should be. The diabetes supplement industry has earned every ounce of your distrust. So I want to be plain about why I think Aurivita is different — and then I'm going to give you a guarantee that takes essentially all the risk off your shoulders.

The mechanism is real. TRPV1 won a Nobel Prize in 2021. Nitric oxide won a Nobel Prize in 1998. The endothelial-dysfunction-as-the-root-of-diabetic-complications model is published, validated, and admitted to on the patient-facing pages of the Mayo Clinic and the Cleveland Clinic. We did not make any of this up. We assembled what was already there.

The label is transparent. Every milligram of every ingredient is listed. There are no proprietary blends. There is no "ancient lost ritual." The ingredients are real, the doses are real, the science is real, and where the science is mixed or limited, I just told you so a few paragraphs ago.

The format is gentle. Softgels, not raw cayenne powder. Designed to be taken with food.

The guarantee is 120 days. Not 30. Not 60. One hundred and twenty days. Take Aurivita for a third of a year. Get bloodwork done. Bring it to your doctor. If you don't see and feel meaningful progress on the things that matter to you — the warmth in your feet, the energy after lunch, the sleep, the numbers on the lab — return whatever's left, even empty bags, and we will refund every dollar. No interrogation. No restocking fee. No "are you sure" upsell.

That is not a marketing trick. That is us putting our money where the science is. If the formula doesn't work for you, we lose money on your order. The only way that math works for us is if it works for most men.

I want you to picture two different futures.

In one future, you keep doing what you're doing. The pills keep getting added. Your A1C keeps creeping. The burning in your feet keeps you up. Your wife stops asking you to dance at weddings because it embarrasses you when you have to sit down. Your daughter gets engaged and you start doing the math on whether you'll still have your sight, your foot, your energy when she walks down the aisle. Your dad's anniversary comes again. And one Tuesday afternoon, sitting in your truck in the parking lot at the cardiology clinic, the doctor uses the word insulin. And you go quiet. Because you knew it was coming. You just didn't know it would be this soon. And eventually — five years, ten years, fifteen years from now — a coroner will sit at a desk and write "heart attack" or "stroke" or "kidney failure" on a piece of paper, and the actual disease that killed you will not appear on it.

In the other future, you start a program — today — that targets the actual mechanism that is taking you apart. You give it 120 days. You watch your feet warm up. You watch your sleep get longer. You watch your A1C bend the wrong direction for the first time in five years. You go to the doctor with bloodwork that surprises both of you. You ask them, for the first time in your adult life, can we talk about taking one of these off the list. You play catch with your grandson without sitting down halfway through. You take you

Fact-check: "Aurivita Capsaicin Power" diabetes supplement copy

A claim-by-claim evaluation of the source marketing copy. Each claim is rated VALIDATED, FALSE / MISLEADING, PLAUSIBLE, or UNLIKELY, with primary sources linked. Research was done via fan-out web search plus a 3-vote adversarial verification pass on the core scientific claims; the supplement-ingredient citations were each checked directly against the cited literature.

Bottom line

This is a "Nobel-laundered" sales letter. The technique is consistent throughout: cite something true and verifiable (a real Nobel Prize, a real Cell Metabolism paper, a real meta-analysis), then quietly let its credibility bleed onto a product the citation never actually tested. Most individual citations are real and surprisingly accurate. The dishonesty lives in the connective tissue — animal data presented as if it were human, a Nobel awarded for one thing implied to be about another, and a 3 mg dose that no human trial supports.

The diabetes / endothelium framing

1. "Coroners write heart attack, not diabetes" — VALIDATED (substance). Real, well-documented underreporting. Studies find only ~35–41% of decedents with diabetes have it listed anywhere on the certificate, and just ~10–16% as the underlying cause. The rhetorical thrust is accurate.

2. "Disease of the blood vessels disguised as a disease of blood sugar" — PARTLY TRUE, OVERREACHES. Endothelial dysfunction genuinely is an early, central driver of diabetic complications, and Cleveland Clinic does list hyperglycemia as a cause of endothelial dysfunction and attributes complications to "damage to your blood vessels and nerves." But no authoritative page redefines diabetes as a vessel disease — they define it as a high-glucose condition that secondarily damages vessels and nerves. The copy drops "nerves" and inverts cause and consequence for rhetorical punch.

3. "Endothelium = largest organ, size of a tennis court" — FALSE (contradicts its own authority). Cleveland Clinic — the source the copy leans on — states the endothelium covers 3,000–6,000 m², roughly 12–23× a tennis court (~260 m²). The "tennis court" line is a widely repeated but wrong pop-science figure.

4. NO mechanism: hyperglycemia/AGEs → oxidative stress → impaired eNOS-NO → poor vasodilation — VALIDATED. Textbook vascular physiology, accurately stated. Caveat: the AGE→eNOS suppression work is largely in-vitro cell culture, so it supports the mechanism, not clinical efficacy of any pill.

5. "Not a single standard drug targets the endothelium — metformin, statins, Ozempic don't" — FALSE / MISLEADING. One of the copy's central claims, and it's wrong. Metformin restores eNOS function and NO bioavailability "beyond glucose control"; GLP-1 agonists (Ozempic) have direct favorable endothelial actions — reduced oxidative stress, increased NO; statins upregulate eNOS. These drugs act on the very organ the copy says they ignore.

The Nobel / TRPV1 narrative

6. Dr. Sarah Hallberg — MOSTLY VALIDATED, one error. Real person; medical director of Virta Health ✓; talk title verbatim ✓; died of lung cancer March 28, 2022 ✓ (never a smoker). Error: the talk is a 2015 TEDx at Purdue, not "2018." View count (12M+) is plausible by 2026 but contemporaneous sources cited ~7M; treat the exact figure as soft.

7. 2021 Nobel Prize — DISTORTED. Julius (UCSF) and Patapoutian did win the 2021 Medicine prize, and Julius did use capsaicin to identify TRPV1 — all true. But the official citation is "for their discoveries of receptors for temperature and touch"sensory perception. The prize had nothing to do with what TRPV1 does in blood vessels. The copy's "it won because of what TRPV1 does in the lining of your blood vessels" is a fabricated rationale.

8. TRPV1 is the capsaicin receptor — VALIDATED. Correct; responds to capsaicin from chili peppers, heat-sensing.

9. Yang et al. 2010, Cell Metabolism — REAL, accurately cited, but ANIMAL ONLY. Every bibliographic detail matches (PMID 20674858, Cell Metabolism 12(2):130–41, title verbatim). The mechanism is faithfully represented. The decisive omission: it was done in mice and rats, and the paper itself says human translation "remains to be established through clinical trials." The copy presents it as if it applies to your toes tonight.

10. 1998 Nobel (Furchgott, Ignarro, Murad, nitric oxide) — VALIDATED exactly as stated.

11. Szallasi 2023 review + Chinese ~9,000-person study — VALIDATED. Real review (Szallasi, Int. J. Molecular Sciences, May 2023, "The Vanilloid (Capsaicin) Receptor TRPV1 in Blood Pressure Regulation"), and the Chinese epidemiological study of 9,273 volunteers linking dietary capsaicin to lower hypertension risk is real. Note: epidemiological association in chili-eating populations ≠ proof a 3 mg softgel does anything.

12. "37 million diabetic Americans" — VALIDATED (mildly stale). CDC's 2022 report said 37.3M. More recent CDC data is now ~38.4–40M, so if anything the figure is conservative.

13. "Medical schools lag 20–30 years" — UNLIKELY / EXAGGERATED. No firm support for 20–30 years. The famous (and itself debated) figure is the ~17-year research-to-practice translation gap (Balas & Boren). The copy inflates a real-but-fuzzy concept into a bigger number to justify "your doctor doesn't know this."

The supplement ingredient citations

Here the copy is, ironically, at its most honest — the meta-analyses are real and the numbers are close to verbatim. The dishonesty is the implication that these published doses are what's in the product.

14. Beetroot, –3.55 mmHg systolic, Advances in Nutrition — VALIDATED, verbatim.

15. Berberine, 2008 Metabolism, 0.5 g 3×/day, ~2% HbA1c drop, comparable to metformin — VALIDATED, verbatim.

16. Cinnamon, 2024 meta-analysis, 28 RCTs, ~3,054 patients, FBG –15.3 mg/dL, HbA1c –0.56% — VALIDATED. (Actual: –15.26 mg/dL.)

17. Curcumin, 2024, 18 RCTs, FBG –11.5 mg/dL, HbA1c –0.54% — VALIDATED. (Actual: –11.48 mg/dL, –0.54%.) BioPerine "~20×" — REAL citation, oversold. Traces to Shoba 1998 (2000% = 20×), but that single result has never been independently replicated, and some trials show piperine adds nothing or worsens outcomes.

18. Korean Red Ginseng, Toronto RCTs, modest glucose/insulin-sensitivity improvement — VALIDATED. Vladimir Vuksan's group at St. Michael's Hospital, Toronto. "Modest" is the honest word — one well-controlled trial showed no HbA1c change but improved insulin sensitivity indices.

19. Vitamin D3 (deficient diabetics) + K2 (calcium routing) — PLAUSIBLE, modest. D3 supplementation gives modest insulin-sensitivity benefit in deficient patients; K2's calcium-routing role is biologically reasonable but clinical evidence in diabetics is thin. Defensible framing, not strong evidence.

20. The 3 mg capsaicin dose — UNLIKELY to be a meaningful oral TRPV1 intervention. The quiet keystone failure. Human capsaicin trials use 4–33 mg/day; 3 mg sits below that range. Worse, controlled human data is mixed and partly contradictory — oral capsaicin has been shown to acutely raise systolic BP in healthy subjects, the opposite of the implied benefit. The animal "lower blood pressure" story does not cleanly reproduce in humans at all, let alone at 3 mg.

Overall assessment of scientific honesty

Where it's honest: Roughly 80% of the discrete factual citations are real and accurately quoted — the Nobel facts, the mechanism, the Yang paper's bibliography, and nearly every ingredient meta-analysis figure (often to the decimal). It also voluntarily includes real disclaimers ("not a cure," "strongest evidence is animal and mechanism studies," "lifestyle is the most powerful lever"). That candor is unusual for the genre and is itself a persuasion tactic — it inoculates against your skepticism.

Where it crosses into misleading marketing — three specific moves:

  1. Species bait-and-switch. The cornerstone capsaicin evidence (Yang 2010) is mice and rats. The entire emotional payload — warm feet, 3 a.m. burning, the bedroom, the A1c — is human clinical outcomes the cited science never demonstrated. The copy's own buried line ("strongest evidence is in animal studies") is the admission.

  2. Authority misattribution. The 2021 Nobel was for sensory receptors; the copy reassigns it to vascular function to manufacture a "two Nobel Prizes point at this pathway" narrative. The 1998 NO prize is real but about basic physiology, not capsaicin or any supplement.

  3. The dose gap. Every validated ingredient figure comes from studies using specific doses (0.5 g berberine 3×/day; beetroot juice; 4–33 mg capsaicin). The product's 3 mg capsaicin — and, almost certainly, sub-clinical amounts of the other nine ingredients — is never reconciled with the doses that produced the cited results. Citing a study that used 1,500 mg/day of berberine to sell a softgel containing a fraction of that is the oldest move in the supplement playbook.

Net: This is not a clumsy scam like the GlucoTrust/Sugar Defender products it explicitly distances itself from — it's a more dangerous competent version, because the verifiable scaffolding is genuinely verifiable. But the load-bearing inference — "therefore this softgel restores your endothelium" — is supported by zero human trials of the actual product, and at least one keystone claim (3 mg lowering anything in humans) runs against the available human evidence. The single most useful sentence in the entire piece is the one buried near the end: this won't do anything that a low-carb diet, weight loss, walking, and your existing medications aren't already doing better and more cheaply.


Caveats: the product's full label and its non-capsaicin doses are not public and were not verified. A couple of nobelprize.org pages returned HTTP 403 on direct fetch and were confirmed via authoritative mirrors that agree verbatim. This is an evaluation of advertising claims, not medical advice.

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment